Navigation Links
Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
Date:9/12/2008

NEW YORK, Sept. 12 /PRNewswire/ -- Exosome Diagnostics, Inc. today announced the appointment of Johan Skog, Ph.D., as director of genetics research. In this role, Dr. Skog will oversee the research program that underlies the company's development of its blood-based diagnostics that can identify cancer-specific genetic mutations.

Dr. Skog is the primary discoverer and inventor of Exosome Diagnostics' core technology that has been licensed exclusively to the company by Massachusetts General Hospital. He is also a post-doctoral researcher at the molecular neurogenetics unit of Massachusetts General Hospital. Dr. Skog received his Ph.D. specializing in gene therapy from Umea University in Sweden.

"Dr. Skog's discoveries are the foundation of our development program to capture diagnostic quantities of genetic mutations in blood," said James McCullough, chairman & chief executive officer. "His expertise as the inventor of the technology of isolating genetic mutations from circulating exosomes for use as diagnostic and prognostic tools will enable the company to rapidly move forward on its first program, a blood-based diagnostic for brain cancer."

About Exosome Diagnostics

Exosome Diagnostics is a developer of proprietary genetics-based diagnostic tests with applications in oncology and endocrinology. Exosome's core technology is based on the discovery that circulating nanovesicles called exosomes contain unique genetic markers and that they can be reliably harvested and used as a diagnostic tool for cancers and metabolic diseases. Exosome Diagnostics' lead program is a blood-based diagnostic test for the management of brain cancer patients. For more information, visit http://www.exosomedx.com.


'/>"/>
SOURCE Exosome Diagnostics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Exosome Diagnostics Announces Additions to Management Team
2. Boveran Diagnostics, Inc. Announces Planned Acquisition of New York-Based Pathology Lab: Sophora Diagnostic Lab, Inc.
3. Pathwork Diagnostics Closes $20M Financing
4. VentriPoint Diagnostics Files Management Discussion and Analysis, Unaudited Financial Results for 2Q 2008
5. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
6. Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics
7. DeviceSpace(TM) to Host Medical Device and Diagnostics Career Fair in Minneapolis
8. Quest Diagnostics to Release Second Quarter 2008 Financial Results
9. VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo for Cancer Research and Diagnostics
10. Premier Healthcare Alliance Honors Siemens Healthcare Diagnostics for Excellence in Supplier Performance
11. HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)...   Merck , a leading science and technology ... set of agreements with Evotec AG, whereby Evotec AG ... reagents such as CRISPR and shRNA libraries. Combining access ... accelerated pathway to explore and identify new drug targets. ... new targets, a process that can be time- and ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... technology applications, introduces the 5th generation, ultra-bright, Laser-Driven Light Source, the EQ-77, at ... Source (LDLS™) technology, the EQ-77 offers higher radiance and irradiance from a truly ...
(Date:11/30/2016)... ... 30, 2016 , ... On 28 November 2016, the International Union of Pure ... (Nh), moscovium (Mc), tennessine (Ts), and oganesson (Og), respectively for element 113, 115, 117, ... by the discoverers have been approved by the IUPAC Bureau. The IUPAC Council will ...
(Date:11/30/2016)... ... November 30, 2016 , ... ProMIS Neurosciences (“ProMIS” or ... neurodegenerative diseases, today announced that all five of its validated monoclonal antibody (mAb) ... of toxic, prion-like forms of Amyloid beta (Aß) in vitro. , “We previously ...
Breaking Biology Technology:
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
Breaking Biology News(10 mins):